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ABSTRACT
Background: Aspergillus is a fungus which may present an array of pulmonary manifestations, depending on the
patient's immunological and physiological state. Although the incidence of pulmonary aspergillosis occurs primarily
in immunocompromised patients but the incidence is also rising in immunocompetent individuals, especially in
developing countries. Aim: The objective of the study was to determine the prevalence and predisposing factors of
pulmonary aspergillosis along with species identification. Materials and Methods: One hundred and three patients
admitted to the Department of Chest and Tuberculosis and in the Department of Medicine from Jan 2012 to Jan
2013  were included  in this  study.  The  patients  were epitomized on the  basis  of clinical  signs  and  symptoms,
physical examination, chest  radiography,  CT scans, histopathological  examination,  bronchoscopy and fungal
examination including potassium hydroxide mount, fungal culture of sputum and bronchoalveolar lavage. Species
identification was done by colony characteristics, slide culture and Lactophenol Cotton blue mount. Results: Out of
the 103 patients, (63 males and 40 females) Aspergillus species has been isolated from 17 (16.5%) males and 07
(6.79%) females. Various predisposing factors of pulmonary aspergillosis have been identified in which pulmonary
tuberculosis, chronic smoking and environmental exposure to asbestos, cement its tops the list. Many of the patients
had multiple predisposing factors. Aspergillus species were isolated in 24 (23.3%) cases. Aspergillus fumigatus was
the  predominant  species  isolated  in  13  (54.16%)  cases  followed  by Aspergillus  flavus in  07  (29.16%)  cases,
Aspergillus niger in 03 (12.5 %) and Aspergillus terrus in 1 (4.16%) cases. Conclusion: It is concluded that the
prevalence of  pulmonary  Aspergillosis  is  quite  high  in immunocompromised  individuals  and  low  in
immunocompetent individuals. An adequate and efficient evaluation of the etiological agents has a crucial role in
the management of such patients.
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INTRODUCTION
In  recent  years  fungal  infections  are  one  of  the
important cause of pulmonary infections.
1 Aspergillus
primarily  affects  the  lungs,  causing a  variety of
manifestations,  including  allergic  bronchopulmonary
aspergillosis  (ABPA),  aspergilloma,  and  invasive
aspergillosis. Invasive  pulmonary  aspergillosis  is  an
increasingly  common  fungal  infection  with  high
morbidity  and  mortality in  immunocompromised
patients.  The incidence  and  clinical  impact of  these
infections  is  on  the  rise  in  the  developed  countries,
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which  is  possibly  related  to  increased  number  of
immunocompromised  patients,  owing  to  improved
survival from AIDS, malignancies and more intensive
cytotoxic  therapy, organ transplantation and  better
treatment and prophylaxis for other fungal infections.
2
Immunocompromised  individuals  are  susceptible  to
pulmonary aspergillosis, but invasive aspergillosis is
extremely  uncommon in individual’s  with  intact
immunity. Immunocompetent persons  seldom develop
this infection and do so only in the presence of other
pulmonary and systemic abnormalities such as fibrotic
lung disease,
3 suppurative infection
4 or treatment with
corticosteroids.
5 Pulmonary  aspergillosis  shows a
variable  inimitable  pattern of  lung  disease  that
primarily depend  on  the  patient's  immune  status.
Preexisting lung  diseases  acts  as  a  significant
predisposing  cause for  pulmonary  aspergillosis.
6,7
Pulmonary  aspergillosis is  generally  presented as a
wide range  of  pulmonary  manifestations, from
aspergilloma with a comparatively benign course, to
invasive  pulmonary  aspergillosis,  which  can  be
terminal. Pulmonary aspergillosis is one of the main
causes  of  pulmonary  infections and creates a
complicated diagnostic  challenge  due  to  lack  of
pathognomonic  clinical  features. The  diagnosis  of
aspergillosis  is  frequently missed  as  the diagnostic
tests  for  their detection  is  not  done in  routine
diagnostic laboratories and/or is not suspected by the
physician.
Therefore,  the  present  study  aims  to a)  detect  the
prevalence  of  pulmonary  aspergillosis  in
immunocompromised  and  immunocompetent
individuals.  b)  To  study  the  various  predisposing
factors.  c)  Isolation  and  differentiation  of
Aspergillus species from clinical specimens of patients
suffering from pulmonary infections.
METHODS
This study  was  conducted  on  103  patients with
different chronic pulmonary infections admitted in the
wards of Department of Chest and Tuberculosis, and
Department  of  Medicine  between  the  period  of
January  2012  to  January  2013. The  cases  are  the
patients with various chronic pulmonary infections of
more  than  one  year on  whom  bronchoscopy,  radio
imaging was done. This work has been approved by
the Institutional Ethical Committee.
Data  were  collected  regarding  age,  sex,  detailed
medical  history  (immunosuppressive  conditions  like
pulmonary tuberculosis, Diabetes mellitus, AIDS etc,
chronic  smoking  and  environmental  exposure  to
asbestos, cement etc smoking), physical examination
(vital  signs,  cyanosis,  pallor,  clubbing  etc),  chest
radiography,  Computed  Tomography (C.T)  scan,
bronchoscopy  etc.  A  complete  blood  picture  and
histopathological  examination were  done.  We  have
considered  the  infections/diseases  as a  prime  risk
factor in patients with multiple risk factors.
The  sputum  and  bronchoalveolar  lavage was
homogenized and direct microscopy was performed by
using 10% KOH mount. It was inoculated on one set
of  Sabouraud's  Dextrose  Agar  (SDA) [HIMEDIA,
MUMBAI] plain  and  SDA  with  Chloramphenicol
(0.05  mg/mL) [HIMEDIA,  MUMBAI] and  also  on
Czapek  Dox  agar [HIMEDIA,  MUMBAI].  The
inoculated SDA were incubated at 25˚C and at 37˚C.
The colony morphology of obverse as well as reverse
was studied.
8 Tease Mount Preparation (TMP) of the
mould isolated was prepared in Lacto Phenol Cotton
Blue  (LPCB)  for  identification  detailed  morphology
including hyphae, phialides, vesicles and spores. The
confirmation  of  fungal  species was  done  by  slide
culture.
9
Statistical analysis: The data were analyzed by using
SPSS  version 17.  The  descriptive  analysis  and  chi
square  test  were  applied.  The  results  obtained  were
presented by using appropriate tables and charts.
RESULTS
A  total  of  103  patients  {63  (61.16%)  males and  40
(38.83 %)} of various age groups with indications of
chronic  pulmonary  infections  were  admitted  in  the
wards of the Hospital during the study period as shown
in Table  1 and Table  2. The  chi  square  test  is
appropriate at 5% level which shows no significance
among  culture  positive  males  and  females  while
significant in age group > 40 years (Elderly).
Aspergillus  species have  been  isolated from  17
(16.5%) males and 07 (6.79%) females. The elderly
patients  (>40 years)  had a  higher  incidence of
pulmonary aspergillosis in males as well as females.
There  are  17  culture  positive  cases  among
immunocompromised  and  07  cases  among
immunocompetent  cases.  Based  on  the  data  of  the
clinical history, the various risk factors like pulmonary
tuberculosis, diabetes mellitus, HIV infection, chronic
smoking,  recurrent  respiratory  tract  infections,
Bronchial  Asthma,  Pleural  effusion,  environmental94
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exposure to asbestos, cement and other chemicals are
documented in Figure 1.
Aspergillus  fumigatus was  the  predominant  species
isolated  from  13  (54.17%)  cases  significant  by  chi
square test, followed by Aspergillus flavus which was
isolated  in 7  (29.17%)  cases,  3  (12.5%)  cases  of
Aspergillus Niger and 1 (4.7 %) case of Aspergillus
terrus as depicted in Table 3 and figure 2.
Table 1: Distribution of culture positive and culture negative patients on the basis of sex.
SEX Culture Positive Patients Culture Negative
Patients
Total P value
MALE 17 46 63 =1.231
P= 0.2671 FEMALE 07 33 40
TOTAL 24 79 103
Table 2: Age group of culture positive and culture negative patients.
Age Group Culture Positive Culture Negative Total P value
0-20 YRS 01 23 24 =6.92
P= 0.0314* 21-40 YRS 08 24 32
>40 YRS 15 32 47
TOTAL 24 79 103 *Significant
Table 3: The incidence of Aspergillus species isolated among patients of chronic lung disease.
SPECIES No. of Positive Cultures Percentage P value
Aspergillus fumigatus 13 54.17% = 6.92
P= 0.0314* Aspergillus flavus 07 29.17%
Aspergillus niger 03 12.5%
Aspergillus terrus 01 4.7 % *Significant
Fig 1: The various risk factors in the patients that may be associated with pulmonary aspergillosis
Note: various patients had multiple risk factors.
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Fig 2: Percentage of Aspergillus species in culture
positive patients.
DISCUSSION
Aspergillus species are common saprobic in the soil,
and their vegetative spores are ever present. Generally,
only immunocompromised patients or the individuals
who  suffer  from  other  chronic  lung  conditions  are
susceptible.  Recently,  reports  of  invasive  pulmonary
aspergillosis  in  immunocompetent  patients  have
increased  in  the  clinical  literature.
10,11
Immunocompetent  patients  are  generally
asymptomatic and only incidentally they are found to
have  aspergillosis.
12-14 Though,  the  rare cases of
pulmonary aspergillosis in patients with intact immune
system have  been  documented.
11 In  recent  time,
reports about  invasive  pulmonary  aspergillosis in
COPD  patients  and  apparently  non-
immunocompromized patients
15-22have been reported.
In our study, the prevalence of pulmonary aspergillosis
was 23.3%. The  prevalence  was  higher  than
Henderson et al
23 who reported an incidence of 11%,
Pepy et al
24 reporting 8% and Campbell and Clayton
8.2 % respectively.
25 This might be due to the more
exposure of the patients to the predisposing factors and
environmental conditions favouring the growth of the
fungus.
Among  the  risk  factors  pulmonary  tuberculosis,
chronic  smoking,  bronchial  Asthma,  bronchogenic
carcinoma was seen.  Multiple risk factors were also
found  in  patients  admitted. Risk  factors  such  as
COPD,  systemic  corticosteroid  therapy,  non-
haematological malignancy,  chronic  renal  disease,
liver  failure,  diabetes  mellitus,  near-drowning,  HIV
infection, etc have been described in earlier studies.
26-
29 The incidence of aspergillosis was more common in
males  as  compared  to  females,  more  in  adults  as
compared to children which may be due to increased
exposure to risk factors. Our study showed a higher
incidence of  Aspergillosis  among
immunocompromised  individuals  and  low  in
immunocompetent individuals. More recently, reports
have described
patients with normal immunity and invasive or semi-
invasive  infections  caused  by Aspergillus species,
most commonly Aspergillus fumigatus, involving the
chest wall
30, brain, middle ear
31, and lung
10,14.
Methods  of  prompt diagnosis  of  pulmonary
aspergillosis are based on  isolation  of Aspergillus in
culture,  serological  methods  and  histopathological
examination which is an invasive method, for which
both  clinicians  and  patients  may  be  reluctant  to
undertake. The  culture  was  positive  in  24  (23.3%)
samples. Aspergillus fumigatus was  the  predominant
species isolated in 13 (54.17%) cases which is in line
with the findings of Bordane et al and Shahid et al.
32, 33
The  other  species  isolated  were Aspergillus flavus,
Aspergillus niger and Aspergillus terrus in 7 (29.17%),
3 (12.5%), and 1 (4.7 %) cases respectively.
CONCLUSION
Finding  of  Aspergillus  species  in  respiratory  tract
samples  in  the  patients  should  not  be  routinely
discarded  as  colonization,  even  if  the  patients  are
immunocompetent
[27]. It is concluded from the present
study that the prevalence of pulmonary Aspergillosis
in immunocompromised as well as immunocompetent
patients is rising in our country; hence, any patient of
chronic  lung  infection  not  responding  to  regular
antibiotic therapy should be investigated for infection
by  Aspergillus. Any  indication  of  aspergillosis,  by
positive  sputum  culture,  serological  tests,  should
compel the physician to initiate anti-fungal treatment.
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